The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
Open accessAbstract
Objective: The Epi-IBD cohort is a prospective population-based inception cohort of unselected patients with inflammatory bowel disease from 29 European centres covering a background population of almost 10 million people. The aim of this study was to assess the 5-year outcome and disease course of patients with Crohn’s disease (CD). Design: Patients were followed up prospectively from the time of diagnosis, including collection of their clinical data, demographics, disease activity, medical therapy, surgery, cancers and deaths. Associations between outcomes and multiple covariates were analysed by Cox regression analysis. Results: In total, 488 patients were included in the study. During follow-up, 107 (22%) patients received surgery, while 176 (36%) patients were hospitalised because of CD. A total of 49 (14%) patients diagnosed with non-stricturing, non-penetrating disease progressed to either stricturing and/or penetrating disease. These rates did not differ between patients from Western and Eastern Europe. However, significant geographic differences were noted regarding treatment: more patients in Western Europe received biological therapy (33%) and immunomodulators (66%) than did those in Eastern Europe (14% and 54%, respectively, P<0.01), while more Eastern European patients received 5-aminosalicylates (90% vs 56%, P<0.05). Treatment with immunomodulators reduced the risk of surgery (HR: 0.4, 95% CI 0.2 to 0.6) and hospitalisation (HR: 0.3, 95% CI 0.2 to 0.5). Conclusion: Despite patients being treated early and frequently with immunomodulators and biological therapy in Western Europe, 5-year outcomes including surgery and phenotype progression in this cohort were comparable across Western and Eastern Europe. Differences in treatment strategies between Western and Eastern European centres did not affect the disease course. Treatment with immunomodulators reduced the risk of surgery and hospitalisation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,959
Gomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J. O., Peyrin-Biroulet, L., Cullen, G. J., Daperno, M., Kucharzik, T., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw168 · Cited by 2,057
D'Haens, G., Baert, F., van Assche, G., Caenepeel, P., Vergauwe, P., Tuynman, H., De Vos, M., van Deventer, S., Stitt, L., Donner, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60304-9 · Cited by 1,231
The burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
Self-citationColombel, J.-F., Panaccione, R., Bossuyt, P., Lukas, M., Baert, F., Vaňásek, T., Danalioglu, A., Novacek, G., Armuzzi, A., Hébuterne, X., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32641-7 · Cited by 921
Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study
Solberg, I. C., Vatn, M. H., Høie, O., Stray, N., Sauar, J., Jahnsen, J., Moum, B., & Lygren, I. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.09.002 · Cited by 698
Vind, I., Riis, L., Jess, T., Knudsen, E., Pedersen, N., Elkjær, M., Andersen, I. B., Wewer, V., Nørregaard, P., Moesgaard, F., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00552.x · Cited by 532
Self-citation
Cited by
The epidemiology of inflammatory bowel disease: East meets west
Mak, W. Y., Zhao, M., Ng, S. C., & Burisch, J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14872 · Cited by 631
Self-citationThe Burden of Inflammatory Bowel Disease in Europe in 2020
Zhao, M., Gönczi, L., Lakatos, P. L., & Burisch, J. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab029 · Cited by 426
Self-citationFeuerstein, J. D., Ho, E. Y., Shmidt, E., Singh, H., Falck-Ytter, Y., Sultan, S., Terdiman, J. P., Sultan, S., Cohen, B. L., Chachu, K., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.022 · Cited by 407
Breaking through the therapeutic ceiling: what will it take?
Raine, T., & Danese, S. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.078 · Cited by 160
Metadata
- Authors
- Burisch, J., Kiudelis, G., Kupcinskas, L., Kievit, H. A. L., Andersen, K. W., Andersen, V., Salupere, R., Pedersen, N., Kjeldsen, J., D’Incà, R., Valpiani, D., Schwartz, D., Odes, S., Olsen, J., Nielsen, K. R., Vegh, Z., Lakatos, P. L., Toca, A., Turcan, S., Katsanos, K. H., Christodoulou, D. K., Fumery, M., Gower-Rousseau, C., Zammit, S. C., Ellul, P., Eriksson, C., Halfvarson, J., Magro, F. J., Duricova, D., Bortlik, M., Fernandez, A., Hernández, V., Myers, S., Sebastian, S., Oksanen, P., Collin, P., Goldis, A., Misra, R., Arebi, N., Kaimakliotis, I. P., Nikuina, I., Belousova, E., Brinar, M., Cukovic-Cavka, S., Langholz, E., & Munkholm, P.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2018-01-23
- Volume
- 68
- Issue
- 3
- Pages
- 423-433
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2785248466
- Cited by
- 294
- References
- 39
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. https://app.cochat.ai/papers/10.1136/gutjnl-2017-315568
- The paper
- Burisch, J., Kiudelis, G., Kupcinskas, L., Kievit, H. A. L., Andersen, K. W., Andersen, V., Salupere, R., Pedersen, N., Kjeldsen, J., D’Incà, R., Valpiani, D., Schwartz, D., Odes, S., Olsen, J., Nielsen, K. R., Vegh, Z., Lakatos, P. L., Toca, A., Turcan, S., . . . Munkholm, P. (2019). Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. https://doi.org/10.1136/gutjnl-2017-315568
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.